Latest Insider Transactions at Biomerica Inc (BMRA)
This section provides a real-time view of insider transactions for Biomerica Inc (BMRA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of BIOMERICA INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of BIOMERICA INC's insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 13
2024
|
Catherine Coste Director |
BUY
Grant, award, or other acquisition
|
Direct |
85,000
+39.76%
|
$0
$0.31 P/Share
|
Dec 13
2024
|
Lu Gary Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
155,000
+50.0%
|
$0
$0.31 P/Share
|
Dec 13
2024
|
Allen Barbieri Executive Vice Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
110,000
+36.87%
|
$0
$0.31 P/Share
|
Dec 13
2024
|
David Moatazedi Director |
BUY
Grant, award, or other acquisition
|
Direct |
85,000
+50.0%
|
$0
$0.31 P/Share
|
Dec 13
2024
|
Zackary S. Irani Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
250,000
+16.44%
|
$0
$0.31 P/Share
|
Dec 13
2024
|
Jane Emerson Director |
BUY
Grant, award, or other acquisition
|
Direct |
85,000
+35.27%
|
$0
$0.31 P/Share
|
May 25
2023
|
Zackary S. Irani Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
200
+0.02%
|
$200
$1.55 P/Share
|
May 24
2023
|
Zackary S. Irani Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
500
+0.05%
|
$500
$1.61 P/Share
|
May 12
2023
|
Zackary S. Irani Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
1,700
+0.17%
|
$1,700
$1.17 P/Share
|
May 10
2023
|
Zackary S. Irani Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
500
+0.05%
|
$500
$1.27 P/Share
|
May 09
2023
|
Zackary S. Irani Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
300
+0.03%
|
$300
$1.39 P/Share
|
May 04
2023
|
Zackary S. Irani Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
1,000
+0.1%
|
$1,000
$1.36 P/Share
|
Apr 28
2023
|
Zackary S. Irani Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
1,800
+0.18%
|
$1,800
$1.34 P/Share
|
Apr 27
2023
|
Zackary S. Irani Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
2,600
+0.25%
|
$2,600
$1.31 P/Share
|
Apr 26
2023
|
Zackary S. Irani Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
7,000
+0.69%
|
$7,000
$1.26 P/Share
|
Jan 27
2023
|
Allen Barbieri Executive Vice Chairman |
BUY
Open market or private purchase
|
Direct |
1,538
+1.5%
|
$3,076
$2.94 P/Share
|
Jan 26
2023
|
Catherine Coste Director |
BUY
Open market or private purchase
|
Direct |
2,190
+4.76%
|
$4,380
$2.96 P/Share
|
Jan 25
2023
|
Zackary S. Irani Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
1,800
+0.18%
|
$3,600
$2.85 P/Share
|
Jan 24
2023
|
Zackary S. Irani Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
2,000
+0.2%
|
$4,000
$2.81 P/Share
|
Oct 26
2020
|
Catherine Coste Director |
BUY
Open market or private purchase
|
Indirect |
9,100
+50.0%
|
$45,500
$5.45 P/Share
|
Oct 05
2020
|
Francis Cano Director |
SELL
Bona fide gift
|
Direct |
20,000
-12.0%
|
-
|